Link transparency Home GSK in France and around the world research CSR at GSK Jobs and careers Media area Link transparency Our medicines / our products Research Link transparency > GlaxoSmithKline laboratory On behalf of : > GlaxoSmithKline Consumer Healthcare > ViiV Healthcare SAS > Glaxo Wellcome Production > GlaxoSmithKline Biologicals > Questions & Answers Home Link transparency Law relating to the strengthening of the health safety of medicines and health products Article 2 - Transparency of links The essential mission of GlaxoSmithKline is to contribute to the improvement of the care of patients both on the therapeutic level by providing them with innovative drugs, and in terms of prevention, thus offering them better prospects in terms of quality and treatment. 'life expectancy. This mission can only be achieved in partnership with, in particular, health professionals. We are convinced that the transparency of relations strengthens the confidence of all actors in the healthcare system. It is in this spirit that GlaxoSmithKline has been engaged for several years in a process of openness in various fields. Within the framework of the law relating to the strengthening of health security of December 29, 2011 aimed at making public certain information concerning the agreements concluded and the advantages granted to nine categories of actors in the health system, we have therefore paid particular attention to meet our obligations that bear the fundamental values of our laboratory. As of October 1, 2013, GlaxoSmithKline will publish information on all of GlaxoSmithKline's activities in France on the website www.gsk.fr under the “Link transparency” section. The following companies also publish their data on this site: - GlaxoSmithKline Santé General Public - ViiV Healthcare SAS - Glaxo Wellcome Production - GlaxoSmithKline Biologicals - Saint-Amand-les-Eaux site This publication concerns the period from January 1, 2012 to June 30, 2013. We will then proceed to two publications per year (on October 1 for the 1st semester data and on April 1 of the following year for the 2nd semester data). This information, available to everyone, will be accessible for a period of 5 years. Our laboratory fully subscribes to the measures which help to improve transparency and prevent conflicts of interest and we fully associate ourselves with this desire of the legislator to make this information public. We adhere to the principles of the HONcode charter . Check it out here . RSS feeds | Add gsk.fr to your favorites | Recommend this site to a friend | Contacts Site map | Legal notices | Supplier Charter Last update October 01, 2013 © 2001 - 2014 GlaxoSmithKline - All rights reserved